COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 1310: Articles 13091-13100  | Next

Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution
Ke, R., Martinez, P., Smith, R. L., Gibson, L., Achenbach, C., McFall, S., Qi, C., Jacob, J., Dembele, E., Bundy, C., Simons, L. M., Ozer, E. A., Hultquist, J. F., Lorenzo-Redondo, R., Opdycke, A., Hawkins, C., Murphy, R., Mirza, A., Conte, M., Gallagher, N., Luo, C. H., Jarrett, J., Conte, A., Zhou, R., Farjo, M., Rendon, G., Fields, C. J., Wang, L., Fredrickson, R., Baughman, M., Chiu, K., Choi, H., Scardina, K., Owens, A., Broach, J., Barton, B., Lazar, P., Robinson, M. L., Mostafa, H., Manabe, Y. C., Pekosz, A., McManus, D., Brooke, C. B.
10.1101/2021.08.30.21262701 — Posted: 2021-09-02 Discussion: Onsite
Covid-19 Vaccine Effectiveness in Healthcare Personnel in six Israeli Hospitals (CoVEHPI)
Katz, M. A., Bron Harlev, E., Chazan, B., Chowers, M., Greenberg, D., Peretz, A., Tshori, S., Levy, J., Yacobi, M., Hirsch, A., Amichay, D., Weinberger, R., Ben Dor, A., Keren Taraday, E., Reznik, D., Barazani Chayat, C., Sagas, D., Ben Zvi, H., Berdinstein, R., Rashid, G., Shemer Avni, Y., Mandelboim, M., Zuckerman, N., Rainy, N., Akriv, A., Dagan, N., Kepten, E., Barda, N., Balicer, R. D.
10.1101/2021.08.30.21262465 — Posted: 2021-09-02
Optimal and worst examination strategies for COVID-19
Onishi, T., Honda, N., Igarashi, Y.
10.1101/2021.08.31.21262868 — Posted: 2021-09-02
Predicting transitions between longitudinal classes of posttraumatic stress disorder, adjustment disorder, and well-being during the COVID-19 pandemic: Protocol of a latent transition model in a general Dutch sample
Lenferink, L. I. M., Mouthaan, J., Fritz, A. M., Soydas, S., Eidhof, M., van Hoof, M.-J., Groen, S., Mooren, T.
10.1101/2021.08.30.21262819 — Posted: 2021-09-02
High-Throughput Adaptable SARS-CoV-2 Screening for Rapid Identification of Dominant and Emerging Regional Variants
Hubler, Z., Song, X., Norris, C., Jani, M., Alouani, D., Atchley, M., Stempak, L. M., Cherian, S. S., Schmotzer, C. L., Sadri, N.
10.1101/2021.08.31.21262625 — Posted: 2021-09-02
Variant abundance estimation for SARS-CoV-2 in wastewater using RNA-Seq quantification
Baaijens, J. A., Zulli, A., Ott, I. M., Petrone, M. E., Alpert, T., Fauver, J. R., Kalinich, C. C., Vogels, C. B. F., Breban, M. I., Duvallet, C., McElroy, K., Ghaeli, N., Imakaev, M., Mckenzie-Bennett, M., Robison, K., Plocik, A., Schilling, R., Pierson, M., Littlefield, R., Spencer, M., Simen, B. B., Yale SARS-CoV-2 Genomic Surveillance Initiative, , Hanage, W. P., Grubaugh, N. D., Peccia, J., Baym, M.
10.1101/2021.08.31.21262938 — Posted: 2021-09-02 Discussion: Onsite
Psychological antecedents towards COVID-19 vaccination using the Arabic 5C validated tool: An online study in 13 Arab countries
Abdou, M. S., Kheirallah, K. A., Aly, M. O., Ramadan, A. M., Elhadi, Y. A. M., Elbarazi, I., Deghidy, E., El Saeh, H. M., Salem, K. M., Ghazy, R. M.
10.1101/2021.08.31.21262917 — Posted: 2021-09-02
How control and relaxation interventions and virus mutations influence the resurgence of COVID-19
Cao, L., Liu, Q.
10.1101/2021.08.31.21262897 — Posted: 2021-09-02
Fine analysis of lymphocyte subpopulations in SARS-CoV-2 infected patients: toward a differential profiling of patients with severe outcome
Clavarino, G., Leroy, C., Epaulard, O., Raskovalova, T., Vilotitch, A., Pernollet, M., Dumestre-Perard, C., Defendi, F., Le Marechal, M., Le Gouellec, A., Audoin, P., Bosson, J.-L., Poignard, P., Roustit, M., Jacob, M.-C., Cesbron, J.-Y.
10.1101/2021.08.31.21262538 — Posted: 2021-09-02
Pharmacokinetic /Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19
Leung, E., Jorgensen, S. C. J., Crass, R. L., Raybardhan, S., Langford, B., Moore, W. J., Rhodes, N. J.
10.1101/2021.08.28.21262692 — Posted: 2021-09-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).